PharMEDium Elects William R. Spalding to Board of Directors

LAKE FOREST, Ill., Aug. 25 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors.

Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services firm that applies extensive operational, financial and transactional expertise to assist companies primarily in the healthcare services industry.  Jonas stated, "Bill's experience in the healthcare services industry and his expertise with respect to matters of strategy, corporate development, operations and governmental affairs equip him well to add value to PharMEDium as a member of our Board of Directors going forward.  He will be an asset."

Mr. Spalding's career experience includes EVP Strategy and Managed Care for CVSCaremark Inc., a Fortune 20 company, and Senior Partner in the Atlanta office of King & Spalding LLP, where he led the Private Equity & Investment Funds Practice and was a member of the firm's management committee.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter <797>, and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.

SOURCE PharMEDium